| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |